Shanghai No.1 Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 29, 2021 at 03:58 am EDT
Share
Shanghai No.1 Pharmacy Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 996.66 million compared to CNY 1,194.69 million a year ago. Revenue was CNY 996.66 million compared to CNY 1,194.69 million a year ago. Net income was CNY 35.97 million compared to CNY 57.68 million a year ago. Basic earnings per share from continuing operations was CNY 0.1612 compared to CNY 0.2585 a year ago. Diluted earnings per share from continuing operations was CNY 0.1612 compared to CNY 0.2585 a year ago.
Shanghai No.1 Pharmacy Co Ltd is a China-based company primarily engaged in the retail and wholesale business of pharmaceuticals. The retail business model mainly purchases medicines, food, medical equipment, health convenience products and other commodities from upstream suppliers, and then retails them to end consumers. The wholesale business model mainly purchases medicines and other commodities from upstream suppliers and then sells them to terminal medical institutions or other pharmaceutical and other commodity circulation companies.
SHANGHAI NO.1 PHARMACY CO.,LTD. 
